Concepedia

Sheri L. Bonar

SL

17

Publications

1.1K

Citations

16

H-Index

1995

Active since

Affiliations

Pfizer (United States)(Current)

Washington University in St. Louis

University of California San Diego

Monsanto (United States)

Purdue University West Lafayette

Sheri L. Bonar is an author at Pfizer (United States) specializing in medicine, natural sciences, and drug discovery.

Top concepts

Publications per year

1995–2018

17

Publications

17

A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts

Nandini Kishore, Cindy Sommers, Sumathy Mathialagan et al. · Journal of Biological Chemistry · 2003 · 273 citations · Full text

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

Timothy P. LaBranche, Michael I. Jesson, Chad Storer et al. · Arthritis & Rheumatism · 2012 · 130 citations

Constitutively Activated NLRP3 Inflammasome Causes Inflammation and Abnormal Skeletal Development in Mice

Sheri L. Bonar, Susannah Brydges, James L. Mueller et al. · PLoS ONE · 2012 · 124 citations · Full text

Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals

Chun Wang, Susan L. Hockerman, E. Jon Jacobsen et al. · The Journal of Experimental Medicine · 2018 · 98 citations · Full text

NLRP3 mediates osteolysis through inflammation‐dependent and ‐independent mechanisms

Chao Qu, Sheri L. Bonar, Cynthia L. Hickman‐Brecks et al. · The FASEB Journal · 2014 · 73 citations · Full text

Rows per page

1–5 of 17